These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [A process of programmed cell death as a mechanisms of neuronal death in prion diseases]. Chrétien F; Dorandeu A; Adle-Biassette H; Ereau T; Wingertsmann L; Brion F; Gray F Clin Exp Pathol; 1999; 47(3-4):181-91. PubMed ID: 10472738 [TBL] [Abstract][Full Text] [Related]
7. Expression of excitatory amino acid transporter-1 (EAAT-1) in brain macrophages and microglia of patients with prion diseases. Chrétien F; Le Pavec G; Vallat-Decouvelaere AV; Delisle MB; Uro-Coste E; Ironside JW; Gambetti P; Parchi P; Créminon C; Dormont D; Mikol J; Gray F; Gras G J Neuropathol Exp Neurol; 2004 Oct; 63(10):1058-71. PubMed ID: 15535133 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes. Kovács GG; Head MW; Hegyi I; Bunn TJ; Flicker H; Hainfellner JA; McCardle L; László L; Jarius C; Ironside JW; Budka H Brain Pathol; 2002 Jan; 12(1):1-11. PubMed ID: 11770893 [TBL] [Abstract][Full Text] [Related]
10. Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200(Lys) mutation. Chapman J; Arlazoroff A; Goldfarb LG; Cervenakova L; Neufeld MY; Werber E; Herbert M; Brown P; Gajdusek DC; Korczyn AD Neurology; 1996 Mar; 46(3):758-61. PubMed ID: 8618678 [TBL] [Abstract][Full Text] [Related]
11. Identification of new molecular alterations in fatal familial insomnia. Llorens F; Thüne K; Schmitz M; Ansoleaga B; Frau-Méndez MA; Cramm M; Tahir W; Gotzmann N; Berjaoui S; Carmona M; Silva CJ; Fernandez-Vega I; José Zarranz J; Zerr I; Ferrer I Hum Mol Genet; 2016 Jun; 25(12):2417-2436. PubMed ID: 27056979 [TBL] [Abstract][Full Text] [Related]
12. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases. Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565 [TBL] [Abstract][Full Text] [Related]
13. [Fatal familial insomnia: phenotypic changes determined by polymorphism of the codon 129]. Colombier C; Géraud G; Delisle MB; Laplanche JL; Pavy le Traon A; Alizé P; Delpla PA Rev Neurol (Paris); 1997 May; 153(4):239-43. PubMed ID: 9296141 [TBL] [Abstract][Full Text] [Related]
15. Cerebral metabolism in fatal familial insomnia: relation to duration, neuropathology, and distribution of protease-resistant prion protein. Cortelli P; Perani D; Parchi P; Grassi F; Montagna P; De Martin M; Castellani R; Tinuper P; Gambetti P; Lugaresi E; Fazio F Neurology; 1997 Jul; 49(1):126-33. PubMed ID: 9222180 [TBL] [Abstract][Full Text] [Related]
16. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Ironside JW; Head MW Curr Top Microbiol Immunol; 2004; 284():133-59. PubMed ID: 15148991 [TBL] [Abstract][Full Text] [Related]
17. Conclusions of the symposium. Gambetti P; Lugaresi E Brain Pathol; 1998 Jul; 8(3):571-5. PubMed ID: 9669714 [TBL] [Abstract][Full Text] [Related]
18. Reduced cerebral blood flow in genetic prion disease with PRNP D178N-129M mutation: an arterial spin labeling MRI study. Chen S; Guan M; Shang JK; He S; Zhang ML; Ma MM; Zhang JW J Clin Neurosci; 2015 Jan; 22(1):204-6. PubMed ID: 25220284 [TBL] [Abstract][Full Text] [Related]
19. The D178N (cis-129M) "fatal familial insomnia" mutation associated with diverse clinicopathologic phenotypes in an Australian kindred. McLean CA; Storey E; Gardner RJ; Tannenberg AE; Cervenáková L; Brown P Neurology; 1997 Aug; 49(2):552-8. PubMed ID: 9270595 [TBL] [Abstract][Full Text] [Related]
20. The prion diseases. Brown K; Mastrianni JA J Geriatr Psychiatry Neurol; 2010 Dec; 23(4):277-98. PubMed ID: 20938044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]